We are live on ! Find out more
RC

RegentAtlantic Capital Portfolio holdings

AUM $3.34B
1-Year Est. Return 14.54%
This Fund
S&P 500
This Quarter Est. Return
-12.69%
1 Year Est. Return
-14.54%
3 Year Est. Return
+23.47%
5 Year Est. Return
+45.3%
10 Year Est. Return
AUM
$1.18B
AUM Growth
-$125M
Cap. Flow
+$58.2M
Cap. Flow %
4.93%
Top 10 Hldgs %
21.66%
Holding
448
New
16
Increased
160
Reduced
197
Closed
47

Sector Composition

Rank Sector Weight
1 Technology 17.81%
2 Healthcare 15.86%
3 Financials 13.24%
4 Industrials 8.14%
5 Communication Services 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMJ
1
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$34.1M 2.89%
1,528,538
+10,940
+0.7% +$277K
AAPL icon
2
Apple
AAPL
$4.71T
$31.8M 2.7%
806,984
-27,200
-3% -$1.32M
IEMG icon
3
iShares Core MSCI Emerging Markets ETF
IEMG
$151B
$30M 2.55%
636,690
+398,086
+167% +$19.2M
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.06T
$26.8M 2.27%
131,305
-2,057
-2% -$430K
MSFT icon
5
Microsoft
MSFT
$2.82T
$25.6M 2.17%
252,008
+63,055
+33% +$6.75M
INTC icon
6
Intel
INTC
$508B
$22.6M 1.91%
481,065
-553
-0.1% -$25.9K
PFE icon
7
Pfizer
PFE
$143B
$22M 1.86%
530,497
+46,978
+10% +$1.95M
JNJ icon
8
Johnson & Johnson
JNJ
$624B
$21.8M 1.85%
169,307
+231
+0.1% +$32.2K
EXC icon
9
Exelon
EXC
$48.2B
$20.4M 1.73%
634,862
+48,279
+8% +$1.54M
PXF icon
10
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.83B
$20.2M 1.71%
538,523
+347,338
+182% +$13.9M
CMCSA icon
11
Comcast
CMCSA
$80.6B
$19.1M 1.62%
560,929
+1,941
+0.3% +$70.9K
ELV icon
12
Elevance Health
ELV
$81.9B
$18.5M 1.57%
70,333
-1,718
-2% -$472K
UNH icon
13
UnitedHealth
UNH
$383B
$15.3M 1.3%
61,461
-709
-1% -$187K
VNQI icon
14
Vanguard Global ex-US Real Estate ETF
VNQI
$3.44B
$14.8M 1.26%
283,074
+267,998
+1,778% +$14.5M
CVS icon
15
CVS Health
CVS
$136B
$13.6M 1.15%
206,858
+42,271
+26% +$3.16M
DIS icon
16
Walt Disney
DIS
$161B
$12.6M 1.07%
114,879
+1,557
+1% +$177K
GOOGL icon
17
Alphabet (Google) Class A
GOOGL
$3.9T
$12.4M 1.05%
237,640
+96,160
+68% +$5.2M
NOC icon
18
Northrop Grumman
NOC
$76.5B
$12.2M 1.03%
49,640
-416
-0.8% -$115K
TMO icon
19
Thermo Fisher Scientific
TMO
$215B
$12.1M 1.03%
54,274
-1,171
-2% -$275K
BAC icon
20
Bank of America
BAC
$427B
$11.7M 0.99%
472,875
-20,197
-4% -$548K
ED icon
21
Consolidated Edison
ED
$41.4B
$11.1M 0.94%
144,940
-15,137
-9% -$1.18M
AMGN icon
22
Amgen
AMGN
$198B
$11M 0.93%
56,539
-2,536
-4% -$495K
ALL icon
23
Allstate
ALL
$65.6B
$10.8M 0.92%
130,934
-982
-0.7% -$88.2K
IWC icon
24
iShares Micro-Cap ETF
IWC
$1.44B
$10.7M 0.91%
130,019
-1,885
-1% -$175K
FNDX icon
25
Schwab Fundamental US Large Company Index ETF
FNDX
$26.3B
$10.5M 0.89%
930,213
-133,947
-13% -$1.65M

Similar funds

RegentAtlantic Capital's Q4 2018 Portfolio in Review

As of Q4 2018, RegentAtlantic Capital held 448 positions worth $1.18B, down 9.6% from $1.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RegentAtlantic Capital deployed $58.2M of net new capital in Q4 2018, opening 16 new positions and adding to 160 existing holdings. Its largest new stake was First Data Corporation: 124,147 shares worth $2.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was DXC Technology, an estimated $6.44M trimmed.

  • RegentAtlantic Capital's largest Q4 2018 buy was First Data Corporation: 124,147 shares worth $2.1M.
  • RegentAtlantic Capital added most to iShares Core MSCI Emerging Markets ETF in Q4 2018, an estimated $19.2M increase.
  • RegentAtlantic Capital's biggest Q4 2018 reduction was DXC Technology, cutting an estimated $6.44M.
  • RegentAtlantic Capital fully exited Aetna Inc in Q4 2018, selling an estimated $17M.
  • RegentAtlantic Capital's ten largest holdings make up 22% of its $1.18B portfolio in Q4 2018.
  • RegentAtlantic Capital opened 16 new positions and closed 47 in Q4 2018.
  • RegentAtlantic Capital's portfolio value fell 9.6% quarter-over-quarter to $1.18B.

Based on RegentAtlantic Capital's 13F filing for Q4 2018, filed 30 Jan 2019.